UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$438M |
| 2 |
Lockheed Martin
LMT
|
+$402M |
| 3 |
TAL Education Group
TAL
|
+$294M |
| 4 |
Microsoft
MSFT
|
+$269M |
| 5 |
Wells Fargo
WFC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$384M |
| 2 |
Adobe
ADBE
|
+$372M |
| 3 |
Veeva Systems
VEEV
|
+$342M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$289M |
| 5 |
Global Payments
GPN
|
+$287M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.1% |
| 2 | Consumer Discretionary | 13.57% |
| 3 | Healthcare | 12.46% |
| 4 | Financials | 11.55% |
| 5 | Communication Services | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACH
1601
Accendra Health
ACH
$92.7M
| $2.14M | ﹤0.01% |
79,200
+7,379
| +10% | +$190K |
|
1602
Simmons First National
SFNC
$3.44B
| $2.14M | ﹤0.01% |
98,907
-3,953
| -4% | -$75.5K |
|
1603
Shenandoah Telecom
SHEN
$755M
| $2.14M | ﹤0.01% |
49,371
| – | – |
|
1604
Edgewell Personal Care
EPC
$1.28B
| $2.13M | ﹤0.01% |
61,665
-11,198
| -15% | -$363K |
|
|
AVNS
1605
DELISTED
Avanos Medical
AVNS
| $2.13M | ﹤0.01% |
46,360
-7,694
| -14% | -$320K |
|
|
EPAY
1606
DELISTED
Bottomline Technologies Inc
EPAY
| $2.12M | ﹤0.01% |
40,286
-4,969
| -11% | -$226K |
|
1607
Vicor
VICR
$9.76B
| $2.12M | ﹤0.01% |
23,037
+4,015
| +21% | +$337K |
|
|
LGF.B
1608
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $2.12M | ﹤0.01% |
203,912
+26,625
| +15% | +$221K |
|
1609
MillerKnoll
MLKN
$1.63B
| $2.11M | ﹤0.01% |
62,523
+2,246
| +4% | +$78.2K |
|
|
VRN
1610
DELISTED
Veren
VRN
| $2.11M | ﹤0.01% |
905,584
-232,573
| -20% | -$398K |
|
1611
Signet Jewelers
SIG
$3.64B
| $2.1M | ﹤0.01% |
77,002
+15,387
| +25% | +$393K |
|
1612
Jack in the Box
JACK
$347M
| $2.1M | ﹤0.01% |
22,597
-1,227
| -5% | -$107K |
|
|
SWN
1613
DELISTED
Southwestern Energy Company
SWN
| $2.09M | ﹤0.01% |
702,263
+53,331
| +8% | +$157K |
|
|
CVSA
1614
Covista Inc
CVSA
$4.34B
| $2.09M | ﹤0.01% |
61,590
-6,149
| -9% | -$175K |
|
1615
Laureate Education
LAUR
$5.03B
| $2.09M | ﹤0.01% |
143,444
+38,660
| +37% | +$546K |
|
1616
Opko Health
OPK
$1.04B
| $2.08M | ﹤0.01% |
526,323
+92,528
| +21% | +$386K |
|
1617
Knowles
KN
$3.3B
| $2.07M | ﹤0.01% |
112,433
+20,240
| +22% | +$338K |
|
|
ALX
1618
Alexander's
ALX
$1.39B
| $2.07M | ﹤0.01% |
7,454
+1,000
| +15% | +$265K |
|
1619
Chesapeake Utilities
CPK
$3.21B
| $2.07M | ﹤0.01% |
19,088
+1,744
| +10% | +$175K |
|
1620
La-Z-Boy
LZB
$1.66B
| $2.07M | ﹤0.01% |
51,837
-3,104
| -6% | -$115K |
|
1621
Immunovant
IMVT
$8.33B
| $2.06M | ﹤0.01% |
44,641
+24,641
| +123% | +$1.14M |
|
|
SC
1622
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $2.05M | ﹤0.01% |
93,190
+18,345
| +25% | +$396K |
|
1623
Goosehead Insurance
GSHD
$2.32B
| $2.05M | ﹤0.01% |
16,395
+4,095
| +33% | +$468K |
|
1624
Pediatrix Medical
MD
$2.13B
| $2.04M | ﹤0.01% |
83,088
| – | – |
|
1625
Arvinas
ARVN
$587M
| $2.04M | ﹤0.01% |
23,988
-164,219
| -87% | -$5.66M |
|
Similar funds
UBS AM's Q4 2020 Portfolio in Review
As of Q4 2020, UBS AM held 2,632 positions worth $213B, up 15% from $186B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
UBS AM's Q4 2020 filing shows 139 new, 1,393 increased, 625 reduced and 83 closed positions. Its largest new stake was Maravai LifeSciences: 3,763,012 shares worth $106M. The largest sale was Mastercard, an estimated $384M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- UBS AM's largest Q4 2020 buy was Maravai LifeSciences: 3,763,012 shares worth $106M.
- UBS AM added most to Apple in Q4 2020, an estimated $438M increase.
- UBS AM's biggest Q4 2020 reduction was Mastercard, cutting an estimated $384M.
- UBS AM fully exited State Street Technology Select Sector SPDR ETF in Q4 2020, selling an estimated $115M.
- UBS AM's ten largest holdings make up 23% of its $213B portfolio in Q4 2020.
- UBS AM opened 139 new positions and closed 83 in Q4 2020.
- UBS AM's portfolio value rose 15% quarter-over-quarter to $213B.
Based on UBS AM's 13F filing for Q4 2020, filed 17 Feb 2021.